Literature DB >> 30762492

Antibiotic Prophylaxis in Pediatric Cardiac Surgery: Where Are We and Where Do We Go? A Systematic Review.

Radoslaw Jaworski1, Andrzej Kansy1, Katarzyna Dzierzanowska-Fangrat2, Bohdan Maruszewski1.   

Abstract

Background: Prophylactic antibiotic therapy is given routinely in the peri-operative period to prevent surgical site infection. However, in pediatric cardiac surgery, an optimal schedule has not been defined. Pediatric recommendations follow the guidelines for adults, which might be improper because of the inherent challenges in pediatric research and the heterogeneity of the population. Implementation of an effective prophylaxis protocol is needed for children undergoing cardiac surgery, especially in view of worldwide antibiotic overuse and the development of drug resistance. In this review, we analyze the current knowledge supported by up-to-date publications about antibiotic prophylaxis in pediatric cardiac surgery.
Methods: The PubMed® database was searched for full-text journal articles describing peri-operative antibiotic prophylaxis in pediatric cardiac surgery published since 2000. Antibiotics used for standard prophylaxis with dosing schema, time of the first dose, additional dosage in extracorporeal circulation (ECC) priming, and prophylaxis duration were analyzed. Additionally, we looked for special clinical situations such as antibiotic prophylaxis in children with the sternum left open after surgery and patients with β-lactam allergy or pre-operative methicillin-resistant Staphylococcus aureus (MRSA) colonization or those requiring extracorporeal membrane oxygenation (ECMO).
Results: A total of 1,546 articles were evaluated, and we identified 20 for further analysis. On the basis of the current peri-operative antibiotic prophylaxis recommendations for cardiac surgery and the papers reviewed, we tried to propose a schedule for peri-operative antibiotic prophylaxis in pediatric cardiac surgery. Conclusions: There is a need for careful use and examination of the schedule proposed because the pharmacokinetics of antibiotics in pediatric patients with ECC is not fully understood. This should be evaluated further. Formulating uniform recommendations concerning peri-operative antibiotic prophylaxis is difficult.

Entities:  

Keywords:  pediatric cardiac surgery; perioperative antibiotic prophylaxis; surgical site infection

Mesh:

Substances:

Year:  2019        PMID: 30762492     DOI: 10.1089/sur.2018.272

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  4 in total

1.  Peri-Operative Prophylaxis in Patients of Neonatal and Pediatric Age Subjected to Cardiac and Thoracic Surgery: A RAND/UCLA Appropriateness Method Consensus Study.

Authors:  Sonia Bianchini; Laura Nicoletti; Sara Monaco; Erika Rigotti; Agnese Corbelli; Annamaria Colombari; Cinzia Auriti; Caterina Caminiti; Giorgio Conti; Maia De Luca; Daniele Donà; Luisa Galli; Silvia Garazzino; Alessandro Inserra; Stefania La Grutta; Laura Lancella; Mario Lima; Andrea Lo Vecchio; Gloria Pelizzo; Nicola Petrosillo; Giorgio Piacentini; Carlo Pietrasanta; Nicola Principi; Matteo Puntoni; Alessandro Simonini; Simonetta Tesoro; Elisabetta Venturini; Annamaria Staiano; Fabio Caramelli; Gaetano Domenico Gargiulo; Susanna Esposito
Journal:  Antibiotics (Basel)       Date:  2022-04-21

2.  Postoperative kinetics of pentraxin 3 (PTX3) after congenital heart surgery with cardiopulmonary bypass in pediatric patients.

Authors:  Radoslaw Jaworski; Katarzyna Dzierzanowska-Fangrat; Renata Grzywa-Czuba; Andrzej Kansy
Journal:  Perioper Med (Lond)       Date:  2022-08-22

3.  Antibiotic prophylaxis for surgical procedures: a scoping review.

Authors:  Eva Brocard; Ludovic Reveiz; Jean-Philippe Régnaux; Veronica Abdala; Pilar Ramón-Pardo; Ana Del Rio Bueno
Journal:  Rev Panam Salud Publica       Date:  2021-05-26

4.  Chlorhexidine bathing of the exposed circuits in extracorporeal membrane oxygenation: an uncontrolled before-and-after study.

Authors:  Hye Ju Yeo; Dohyung Kim; Mihyang Ha; Hyung Gon Je; Jeong Soo Kim; Woo Hyun Cho
Journal:  Crit Care       Date:  2020-10-06       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.